Floatz logo

Capsaicin

Cluster Headache

The University of Texas Health Science Center, HoustonSmall moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Cluster Headache cohort.

Asset / SponsorPhaseRating
Galcanezumab
Eli Lilly and Company
Phase 3BB
IMMUNOGLOBULIN G, ANTI-(HUMAN CALCITONIN GENE-RELATED PEPTIDE RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER
Charite University, Berlin, Germany
Phase 2B
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Stanford University
Phase 2CCC
Pasireotide
Novartis Pharmaceuticals
Phase 2CCC
DEXAMETHASONE
Weill Medical College of Cornell University
Phase 1CC

View all 9 →

Same molecule, other indications

Capsaicin is also rated in:

peripheral nervous system disorderDormant
A
Indicative ·
81 / 100
View asset →
diabetic neuropathyDormant
BBB
Indicative ·
78 / 100
View asset →
postherpetic neuralgiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →